Lista de obras - Aijaz Ahmed - Dominio Público Uruguay

Alcoholic Liver Disease replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States.

artículo científico publicado en 2017

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.

artículo científico publicado en 2017

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD

artículo científico publicado en 2018

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States

scientific article published in PLoS ONE

Association of Pre-Transplant Renal Function with Liver Graft and Patient Survival after Liver Transplantation in Patients with Nonalcoholic Steatohepatitis

artículo científico publicado en 2019

Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis

artículo científico publicado en 2017

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation.

artículo científico publicado en 2018

Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

artículo científico publicado en 2019

Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

artículo científico publicado en 2018

Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.

artículo científico publicado en 2016

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

artículo científico publicado en 2017

Depression is associated with non-alcoholic fatty liver disease among adults in the United States

artículo científico publicado en 2019

Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality

scientific article published on 27 January 2020

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome.

artículo científico publicado en 2016

Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients

artículo científico publicado en 2017

Disparate Trends in Mortality of Etiology-specific Chronic Liver Disease Among Hispanic Sub-Populations

scientific article published on 01 November 2018

Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices

artículo científico publicado en 2016

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016

article

Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States

artículo científico publicado en 2019

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD

artículo científico publicado en 2018

Equitable Access to All-Oral Direct-Acting Antiviral Therapy is a Mandatory Step to Achieve Global Hepatitis C Virus Eradication.

artículo científico publicado en 2017

Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients

artículo científico publicado en 2018

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals

artículo científico publicado en 2017

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

scientific article published on 01 March 2020

Hepatic encephalopathy: what the multidisciplinary team can do.

artículo científico publicado en 2017

Hepatitis C in Pregnancy.

artículo científico publicado en 2018

High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California

artículo científico publicado en 2020

Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States

Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis

artículo científico publicado en 2019

Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents.

artículo científico publicado en 2017

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2020

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients with Primary Biliary Cholangitis

artículo científico publicado en 2018

Increasing Trends in Transplantation of Hepatitis C Virus-Positive Livers Into Uninfected Recipients

artículo científico publicado en 2018

Indications for antiviral therapy for chronic hepatitis B in pregnant mothers

artículo científico publicado en 2016

Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.

artículo científico publicado en 2017

Judicious Use of Lipid Lowering Agents in the Management of NAFLD

artículo científico publicado en 2018

Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis

artículo científico publicado en 2018

Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes

artículo científico publicado en 2017

Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis

artículo científico publicado en 2019

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

artículo científico publicado en 2018

Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies.

artículo científico publicado en 2018

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft

scientific article published on 28 July 2018

Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges

artículo científico publicado en 2016

Nutritional Needs and Support for Children with Chronic Liver Disease

artículo científico publicado en 2017

Optimal timing for hepatitis C antiviral therapy in the peritransplant period?

artículo científico publicado en 2017

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis

artículo científico publicado en 2017

Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox

artículo científico publicado en 2020

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary

scientific article published on 13 May 2019

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

artículo científico publicado en 2018

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease

article

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016

artículo científico publicado en 2019

Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents.

artículo científico publicado en 2017

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study

artículo científico publicado en 2019

Recent Epidemiology of Nonalcoholic Fatty Liver Disease

scientific article published on 15 September 2020

Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis

artículo científico publicado en 2017

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States

artículo científico publicado en 2017

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease.

artículo científico publicado en 2017

Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.

artículo científico publicado en 2018

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience

artículo científico publicado en 2017

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease

artículo científico publicado en 2019

Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C.

artículo científico publicado en 2016

Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States

artículo científico publicado en 2019

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2019

The Role of Cannabinoids in the Setting of Cirrhosis.

artículo científico publicado en 2018

The Role of Vitamin E in the Treatment of NAFLD

artículo científico publicado en 2018

The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C.

artículo científico publicado en 2017

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD

artículo científico publicado en 2019

The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study

artículo científico publicado en 2020

The importance of a multidisciplinary approach to hepatocellular carcinoma

scientific article published on 20 March 2017

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents

artículo científico publicado en 2017

Treating Alcohol Use Disorder in Chronic Liver Disease

scientific article published on 01 February 2020

Treatment of inoperable hepatocellular carcinoma with immunotherapy

artículo científico publicado en 2019

Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States

artículo científico publicado en 2017

Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014

artículo científico publicado en 2020

Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule

artículo científico publicado en 2016

Trends in Mortality in Hepatitis C Infection and Alcoholic Liver Disease based on Drug Overdose in the United States

scientific article published on 04 November 2020

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014

scientific article published on 04 June 2019

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017

scientific article published on 22 April 2019

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era

Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher

scientific article published on 25 September 2016

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis

scientific article published on 12 December 2018

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates

artículo científico publicado en 2018

Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy

artículo científico publicado en 2018

When to Initiate Weight Loss Medications in the NAFLD Population

artículo científico publicado en 2018

Lista de obras de Aijaz Ahmed

Alcoholic Liver Disease replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States.

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States

Association of Pre-Transplant Renal Function with Liver Graft and Patient Survival after Liver Transplantation in Patients with Nonalcoholic Steatohepatitis

Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation.

Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

Depression is associated with non-alcoholic fatty liver disease among adults in the United States

Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome.

Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients

Disparate Trends in Mortality of Etiology-specific Chronic Liver Disease Among Hispanic Sub-Populations

Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016

Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD

Equitable Access to All-Oral Direct-Acting Antiviral Therapy is a Mandatory Step to Achieve Global Hepatitis C Virus Eradication.

Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Hepatic encephalopathy: what the multidisciplinary team can do.

Hepatitis C in Pregnancy.

High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California

Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States

Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis

Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents.

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients with Primary Biliary Cholangitis

Increasing Trends in Transplantation of Hepatitis C Virus-Positive Livers Into Uninfected Recipients

Indications for antiviral therapy for chronic hepatitis B in pregnant mothers

Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.

Judicious Use of Lipid Lowering Agents in the Management of NAFLD

Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis

Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes

Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies.

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft

Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges

Nutritional Needs and Support for Children with Chronic Liver Disease

Optimal timing for hepatitis C antiviral therapy in the peritransplant period?

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis

Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016

Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents.

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study

Recent Epidemiology of Nonalcoholic Fatty Liver Disease

Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease.

Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease

Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C.

Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease

The Role of Cannabinoids in the Setting of Cirrhosis.

The Role of Vitamin E in the Treatment of NAFLD

The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C.

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD

The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study

The importance of a multidisciplinary approach to hepatocellular carcinoma

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents

Treating Alcohol Use Disorder in Chronic Liver Disease

Treatment of inoperable hepatocellular carcinoma with immunotherapy

Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States

Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014

Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule

Trends in Mortality in Hepatitis C Infection and Alcoholic Liver Disease based on Drug Overdose in the United States

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017